The Global Single-cell multi-omics market fuelled the market growth owing to advancement in technology and spurred in chronic diseases. The Global single-cell multi-omics market will emerge with a significant CAGR in the forecast period from 2020-2027. A variety of omics single-cell technologies have been allowing researchers to understand the status of every single cell more precisely, especially for tumors. The research on the occurrence and development of embryos, embryonic development, and complex tissues is more in-depth.
The rapid development of single-cell analysis technology is due to analytical tools, such as cell separation, microfluidics, single-cell sequencing, and so on. The application of single-cell analysis has involved many fields, including basic research applications, such as cancer, immunology, neurology, stem cells, etc., clinical applications, such as non-invasive prenatal diagnosis, in vitro fertilization, and circulating tumor cells (CTCs).
Moreover, rising non-invasive instruments, increasing demand for personalized medicines, and enhancing infrastructure for testing drugs are fueling the healthcare industry. Additionally, the market demand for single-cell multi-omics has emerged owing to the propelling chronic diseases such as cancer, tumors, etc.
Product Overview in the Global single cell multi omics Market
Based on the product, the global single-cell multi-omics market segmented into Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics. The single-cell transcriptomics segment has captured the highest market value in the global single-cell multi-omics market in the forecast period from 2020-2027. Transcriptome sequencing can detect the overall transcription activity of any species without designing probes for known sequences in advance. It provides accurate digital signals, higher detection throughput, and a more extensive range detection that is a powerful tool for an in-depth study of the complexity of the transcriptome.
Application Overview in the Global single cell multi omics Market
Based on the Application, the global single-cell multi-omics market classified into Oncology, Cell Biology, Neurology, Immunology, Others. The Oncology segment has dominated the demand of the worldwide single-cell multi-omics market due to rising diseases like cancer, neurology disease, cardiovascular disease. Thus, oncology helps in identifying the origin of disseminated tumor cells in the breast, brain, and any other parts in the body.
Region Overview in the Global single cell multi omics Market
Based on geography, the global single-cell multi-omics market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. The North America region is going to dominate the market growth of the single-cell multi-omics in the global market in the forecast period from 2020-2027. Owing to rising disposable income, improving healthcare infrastructure, and advance non-invasive instruments have bolstered the demand for the global single-cell multi-omics market.
Global single cell multi omics Market: Competitive Landscape
Companies such as 10x Genomics, Inc., MissionBio, 1CellBio, NanoString Technologies, Inc., Fluxion Biosciences, Fluidigm Corporation, Celsee, Inc., Bio-Rad Laboratories, Inc., BGI Genomics Co. Ltd., GE LifeSciences, Illumina, Inc., and Takara Bio, QIAGEN N.V., among others, are key players in the global single-cell multi-omics market.
1. Research Strategic Development
1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation
2. Research Methodology
2.1. Identification of Target Market
2.2. Data Acquisition
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation
3. Executive Summary
4. Market Insights
4.1. Economic Factor Analysis
4.1.1. Drivers
4.1.2. Trends
4.1.3. Opportunities
4.1.4. Challenges
4.2. Competitors & Product Analysis
4.3. Regulatory Framework
4.4. Company market share analysis, 2019
4.5. Porter’s Five forces analysis
4.6. New Investment Analysis
4.7. PESTEL Analysis
5. Global Single Cell Multi Omics Market Overview
5.1. Market Size & Forecast, 2016-2027
5.1.1. Demand
5.1.1.1. By Value (USD Million)
5.2. Market Share & Forecast, 2016-2027
5.2.1. By Product Type
5.2.1.1. Single Cell Genomics
5.2.1.2. Single Cell Proteomics
5.2.1.3. Single Cell Transcriptomics
5.2.1.4. Single Cell Metabolomics
5.2.2. By Application
5.2.2.1. Oncology
5.2.2.2. Cell Biology
5.2.2.3. Neurology
5.2.2.4. Immunology
5.2.2.5. Others
5.2.3. By Region
5.2.3.1. Europe
5.2.3.2. North America
5.2.3.3. Asia Pacific
5.2.3.4. South America
5.2.3.5. Middle East & Africa
6. Europe Single Cell Multi Omics Market Overview
6.1. Europe Single Cell Multi Omics Size & Forecast, 2016-2027
6.1.1. Demand
6.1.1.1. By Value (USD Million)
6.2. Europe Single Cell Multi Omics Market Share & Forecast, 2016-2027
6.2.1. By Product Type
6.2.1.1. Single Cell Genomics
6.2.1.2. Single Cell Proteomics
6.2.1.3. Single Cell Transcriptomics
6.2.1.4. Single Cell Metabolomics
6.2.2. By Application
6.2.2.1. Oncology
6.2.2.2. Cell Biology
6.2.2.3. Neurology
6.2.2.4. Immunology
6.2.2.5. Others
6.2.3. By Country
6.2.3.1. Germany
6.2.3.2. UK
6.2.3.3. France
6.2.3.4. Italy
6.2.3.5. Rest of Europe
6.2.4. Company Market Share (Top 3-5)
6.2.5. Economic Impact Study on Europe Single Cell Multi Omics Market
7. North America Single Cell Multi Omics Market Overview
7.1. North America Single Cell Multi Omics Market Size & Forecast, 2016-2027
7.1.1. Demand
7.1.1.1. By Value (USD Million)
7.2. North America Single Cell Multi Omics Market Share & Forecast, 2016-2027
7.2.1. By Product Type
7.2.1.1. Single Cell Genomics
7.2.1.2. Single Cell Proteomics
7.2.1.3. Single Cell Transcriptomics
7.2.1.4. Single Cell Metabolomics
7.2.2. By Application
7.2.2.1. Oncology
7.2.2.2. Cell Biology
7.2.2.3. Neurology
7.2.2.4. Immunology
7.2.2.5. Others
7.2.3. By Country
7.2.3.1. US
7.2.3.2. Canada
7.2.3.3. Mexico
7.2.4. Company Market Share (Top 3-5)
7.2.5. Economic Impact Study on North America Single Cell Multi Omics Market
8. Asia Pacific Single Cell Multi Omics Overview
8.1. Asia Pacific Single Cell Multi Omix Market Size & Forecast, 2016-2027
8.1.1. Demand
8.1.1.1. By Value (USD Million)
8.2. Asia Pacific Single Cell Multi Omics Market Share & Forecast, 2016-2027
8.2.1. By Product Type
8.2.1.1. Single Cell Genomics
8.2.1.2. Single Cell Proteomics
8.2.1.3. Single Cell Transcriptomics
8.2.1.4. Single Cell Metabolomics
8.2.2. By Application
8.2.2.1. Oncology
8.2.2.2. Cell Biology
8.2.2.3. Neurology
8.2.2.4. Immunology
8.2.2.5. Others
8.2.3. By Country
8.2.3.1. China
8.2.3.2. India
8.2.3.3. Japan
8.2.3.4. Australia
8.2.3.5. Rest of Asia Pacific
8.2.4. Company Market Share (Top 3-5)
8.2.5. Economic Impact Study on Asia Pacific Single Cell Multi Omics Market
9. South America Single Cell Multi Omics Market Overview
9.1. South America Single Cell Multi Omics Market Size & Forecast, 2016-2027
9.1.1. Demand
9.1.1.1. By Value (USD Million)
9.2. South America Single Cell Multi Omics Market Share & Forecast, 2016-2027
9.2.1. By Product Type
9.2.1.1. Single Cell Genomics
9.2.1.2. Single Cell Proteomics
9.2.1.3. Single Cell Transcriptomics
9.2.1.4. Single Cell Metabolomics
9.2.2. By Application
9.2.2.1. Oncology
9.2.2.2. Cell Biology
9.2.2.3. Neurology
9.2.2.4. Immunology
9.2.2.5. Others
9.2.3. By Country
9.2.3.1. Brazil
9.2.3.2. Argentina
9.2.3.3. Rest of South America
9.2.4. Company Market Share (Top 3-5)
9.2.5. Economic Impact Study on South America Single Cell Multi Omics Market
10. Middle East & Africa Single Cell Multi Omics Market Overview
10.1. Middle East & Africa Single Cell Multi Omics Market Size & Forecast, 2016-2027
10.1.1. Demand
10.1.1.1. By Value (USD Million)
10.2. Middle East & Africa Single Cell Multi Omics Market Share & Forecast, 2016-2027
10.2.1. By Product Type
10.2.1.1. Single Cell Genomics
10.2.1.2. Single Cell Proteomics
10.2.1.3. Single Cell Transcriptomics
10.2.1.4. Single Cell Metabolomics
10.2.2. By Application
10.2.2.1. Oncology
10.2.2.2. Cell Biology
10.2.2.3. Neurology
10.2.2.4. Immunology
10.2.2.5. Others
10.2.3. By Country
10.2.3.1. Saudi Arabia
10.2.3.2. UAE
10.2.3.3. South Africa
10.2.3.4. Rest of Middle East & Africa
10.2.4. Company Market Share (Top 3-5)
10.2.5. Economic Impact Study on Middle East & Africa Single Cell Multi Omics Market
11. Competitor Analysis
11.1. Company Description
11.2. Financial Analysis
11.3. Key Products
11.4. Key Management Personnel
11.5. Contact Address
11.6. SWOT Analysis
11.7. Company Profile
11.7.1. 10x Genomics, Inc.
11.7.2. 1CellBio
11.7.3. MissionBio
11.7.4. NanoString Technologies, Inc.
11.7.5. Fluidigm Corporation
11.7.6. Fluxion Biosciences
11.7.7. Bio-Rad Laboratories, Inc.
11.7.8. Celsee, Inc.
11.7.9. BGI Genomics Co. Ltd. GE LifeSciences
11.7.10. Illumina, Inc.
11.7.11. Takara Bio
11.7.12. QIAGEN N.V.
11.7.13. Other players.